KaloCyte

Overview

KaloCyte has demonstrated proof of concept for ErythroMer, a dried, bio-inspired artificial red blood cell envisioned for use when stored red blood cells are unavailable, undesirable or in short supply. Supported by nearly $6M in federal awards and investor funding, KaloCyte was founded by a distinguished team of researchers in physiology, bioengineering, and trauma care, with support from the BioGenerator Fundamentals program in St. Louis, Missouri.